Bowel Cancer Screening Programme announces first results

December 8, 2011 in Cancer

The Bowel Cancer Screening Programme in England is on track to cut bowel cancer deaths by its target of 16%, reveals an analysis of the first one million test results, published in Gut.

But the results also show a much higher proportion of cancers detected were left sided, suggesting that different strategies may need to be deployed to pick up disease on both sides of the body, as right sided cancers are thought to be more aggressive, say the authors.

kills 16,000 people every year in the UK and is second only to as the leading cause of in both the UK and Europe.

Survival from bowel cancer is still only around 50% in the UK, and significantly lower than in other comparable countries.

The authors base their findings on an analysis of the first 1.08 million faecal occult blood tests, returned by patients invited for the first round of bowel in England.

The programme started in 2006 and was rolled out nationwide by the end of 2009 for those between the ages of 60 and 69. It involves three tests every two years, and has since been extended to those over 70.

Up to October 2008, over two million people had been invited to participate, with around half of those invitations accepted - just under 50% for men and almost 55% for women.

Returns were higher in the four provincial hubs, averaging 55-60%, but were lower in London, where they averaged 40%.

In all, 2.5% of men and 1.5% of women (21,106 people in all) had an abnormal test result out of the 1.08 million returns, and 17,518 people were investigated further.

Most underwent - a procedure involving a long tube with a camera on the end that is inserted into the back passage.

Men were more likely to have cancer and its immediate ("higher risk ") than women.

These were found in around one in eight (11.6%) and around four out of 10 (43%) men, respectively, compared with just under 8% and 29%, respectively, of the women.

Seven out of 10 cancers (71%) picked up by the screen were early stage disease, and as expected, right sided cancer was more common in women than in men.

But left sided cancers were considerably more common than expected, based on figures drawn from cancer registries.

These figures indicated that around two thirds of bowel cancers (67%) picked up by the screening programme would be left sided and around one in four (24%) would be right sided.

Instead, more than three out of four (77%) cancers detected by screening were left sided, compared with 14% that were right sided.

The authors point to research suggesting that right sided cancers are more aggressive and less likely to be picked up by screening. "Different screening strategies may be required to effectively screen for right-sided bowel cancer," they conclude.

Provided by British Medical Journal search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    created13 hours ago
  • Popping/Cracked sternum.
    created18 hours ago
  • Which Mental Illness Encompasses This Problem?
    created18 hours ago
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created May 25, 2012 | popularity not rated yet | comments 1


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.